Malignant Melanoma
📧 Sign up to get email alerts when something new happens for Malignant Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012) [Phase 2]
This is a Phase 2 clinical study evaluating the combination of Intismeran Autogene (V940) and pembrolizumab (MK-3475) for malignant melanoma…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Reducing Symptom Burden Through Physical Exercise in Melanoma Patients [NA]
A clinical trial is evaluating whether a structured physical exercise program can reduce symptom burden in patients with malignant melanoma.…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma [Phase 3]
Phase 3 trial assessing short immunotherapy after radical surgery in patients with high-risk malignant melanoma; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Gastrointestinal Microbiome and Response to Immunotherapy in Metastatic Malignant Melanoma [NA]
This entry provides an update on a clinical trial investigating how the gastrointestinal microbiome influences response to immunotherapy in …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports a Phase Ib/II study of TCC1727 in combination therapy for advanced solid tumors, including non-small cell…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma [Phase 1, Phase 2]
A Phase I/II clinical trial evaluating JMT108 Injection for unresectable locally advanced or metastatic malignant melanoma is currently recr…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC [Phase 1]
Phase 1 trial evaluating LB-LR1109 alone and in combination with atezolizumab for solid tumors, including non-small cell lung cancer, curren…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis [NA]
Clinical trial update on fecal microbiota transplantation to treat checkpoint inhibitor–induced diarrhea and colitis; currently RECRUITING a…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
An observational clinical trial from OncoHost Ltd. aims to predict responsiveness to anti-cancer treatments in patients with advanced cancer…
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer [Phase 2]
Phase 2 study evaluating the performance of Gallium-68 labeled FAPI PET/CT for cancer imaging, including patients with malignant melanoma st…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Modified Vaccine for High Risk or Low Residual Melanoma Patients [Phase 1, Phase 2]
Clinical trial update describing a phase 1/2 study of a modified vaccine for patients with high-risk or low residual malignant melanoma; rec…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer [Phase 1]
Chiome Bioscience's CBA-1205, an anti-DLK1 monoclonal antibody, is in a Phase I first-in-human trial for advanced solid tumors including hep…
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Video-Tumorboard PLUS
A clinical trial update for Video-Tumorboard PLUS focusing on malignant melanoma using telemedicine indicates the study is currently recruit…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy [Phase 2]
Phase 2 clinical trial evaluating immune PET imaging and proteomics to assess response to spatially fractionated or palliative radiotherapy …
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients With Metastatic Malignant Melanoma Treated With Targeted Therapies or Immunotherapy ( MALT ) [NA]
This completed clinical trial investigates using plasmatic cell-free BRAF and NRAS mutations as a blood-based biomarker to monitor patients …
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary
Clinical trial update describing ongoing recruitment for a national cohort study of patients with malignant melanoma (resectable stage II–IV…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma [NA]
A randomized trial to evaluate the role of imaging during follow-up after radical surgery in high-risk malignant melanoma.
-
CLINICAL_TRIALS research · 2024-07-10Clinical Trial Update: Identification of Olfactory Biomarkers of Skin Cancer From Skin Odor Samples: a Pilot Study [NA]
A pilot clinical trial aims to identify volatile biomarkers in skin odor that differentiate malignant melanoma, basal cell carcinoma, and sq…
-
CLINICAL_TRIALS research · 2016-10-25Clinical Trial Update: Definition of an Immune Signature Predictive of Anti-PD1 (Programmed Death-1) Antibody in the Treatment of Advanced Melanoma
This update describes a study aimed at defining an immune signature that predicts response to anti-PD-1 antibodies in advanced melanoma. The…
-
CLINICAL_TRIALS research · 2016-06-07Clinical Trial Update: In-hospital Neutron Irradiator (IHNI)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Malignant Melanoma [Phase 1, Phase 2]
This clinical trial registry entry describes an IHNI-based boron neutron capture therapy approach being studied for malignant melanoma in Ph…
-
CLINICAL_TRIALS research · 2010-08-11Clinical Trial Update: International Melanoma Algorithm Training Study - IMATS [NA]
A completed clinical trial update for the IMATS international melanoma algorithm training study sponsored by SciBase AB. The study concerns …
-
CLINICAL_TRIALS research · 2010-06-25Clinical Trial Update: Quality of Life and Psychological Well-being in Patients With Malignant Melanoma [NA]
This document provides an update on a clinical trial assessing quality of life and psychological well-being in patients with malignant melan…
-
CLINICAL_TRIALS research · 2008-04-01Clinical Trial Update: Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma [Phase 2]
Phase 2 safety and efficacy study of INGN 241 gene therapy in patients with in-transit malignant melanoma.
-
CLINICAL_TRIALS research · 2007-09-27Clinical Trial Update: MicroRNA Expression and Function in Cutaneous Malignant Melanoma
This clinical trial update describes research about microRNA expression and function in malignant melanoma, aiming to understand molecular m…
-
CLINICAL_TRIALS research · 2006-10-12Clinical Trial Update: IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma [Phase 2]
Phase 2 trial evaluating intravenous immunoglobulin (IVIG) for metastatic prostate, colon, and malignant melanoma cancers; current status is…